Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism

Cytokine

Volumn 12, Issue 2, 2000, Pages 110-119

  Kroeger, Karen M ^a   Steer, James H ^a   Joyce, David A ^a   Abraham, Lawrence J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Diabetes; Induction; Polymorphism; TNF; Transcription

Indexed keywords

GAMMA INTERFERON; LIPOPOLYSACCHARIDE; PHORBOL 13 ACETATE 12 MYRISTATE; RETINOIC ACID; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR;

ARTICLE; CELL STRAIN U937; DNA POLYMORPHISM; DNA PROTEIN COMPLEX; GENETIC TRANSCRIPTION; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0033934788     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1999.0529     Document Type: Article

References (33)

1. Wilson AG, di Giovine FS, Blakemore AIF, Duff GW. Single base change in the human tumor necrosis factor alpha (TNF-α) gene detectable by Nco I restriction of PCR product. Human Mol Genet. 1:1992;353.
2. D'Alfonso S, Richiardi PM. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics. 39:1994;150-154.
3. Hamann A, Mantzoros C, Vidal-Puig A, Flier JS. Genetic variability in the TNF promoter is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Comm. 211:1995;833-839.
4. Uglialoro AM, Turbay D, Pesavento PA, McKenzie FE, Delgado JC, Gribben JG, Harti D, Edmond JY, Goldfeld AE. Identification of three new single nucleotide polymorphisms in the human TNF-α gene promoter. Eur Cytokine Netw. 18:1998;A-21.
5. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LBA, Duff GW. An allelic polymorphism within the human tumor necrosis factor α promoter region is strongly associated with HLA-A1, B8, DR3 alleles. J Exp Med. 177:1993;557-560.
6. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor α: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci U S A. 87:1990;1233-1237.
7. Abraham LJ, French MAH, Dawkins RL. Polymorphic MHC ancestral haplotypes affect the activity of tumor necrosis factor alpha. Clin Exp Immunol. 92:1993;14-18.
8. Pociot F, Briant L, Jongeneel CV, Molvig J, Worsaae H, Abbal M, Thomsen M, Neurp J, Cambon-Thomsen A. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol. 23:1993;224-231.
9. Wilson AG, Gordon C, di Giovine FS, de Vries N, van de Putte LBA, Emery P, Duff GW. A genetic association between systemic lupus erythamatosus and tumor necrosis factor alpha. Eur J Immunol. 24:1994;191-195.
10. Candore G, Cigna D, Gervasi F, Colucci AT, Modica MA, Caruso C. In vitro cytokine production by HLA-B8,DR3 positive subjects. Autoimmunity. 18:1994;121-132.
11. Bouma G, Crusius JBA, Oudkerk Pool M, Kolkman JJ, Von Blomberg BME, Kostense PJ, Giphart MJ, Schreuder GM, Meuwissen SGM, Pena AS. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles - relevance for inflammatory bowel disease. Scand J Immunol. 43:1996;456-463.
12. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature. 371:1994;508-511.
13. Cabrera M, Shaw M-A, Sharples C, Williams H, Castes M, Convit J, Blackwell JM. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med. 182:1995;1259-1264.
14. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-α promoter polymorphism effects transcription. Mol Immunol. 34:1997;391-399.
15. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci U S A. 94:1997;3195-3199.
16. Kroeger KM, Abraham LJ. Identification of an AP-2 element in the -323 to -285 region of the TNF-α gene. Biochem Mol Biol Int. 40:1996;43-51.
17. Li Y, Ross J, Scheppler JA, Franza BR. An in vitro transcriptional analysis of early responses of the human immunodeficiency virus type I long terminal repeat to different transcriptional activators. Mol Cell Biol. 11:1991;1883-1893.
18. Beutler B, Cerami A. Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature. 320:1986;584-588.
19. Hensel G, Mannel DN, Pfizenmaier K, Kronke M. Autocrine stimulation of TNF-alpha mRNA expression in HL-60 cells. Lymphokine Res. 6:1987;119-125.
20. Leitman D, Ribeiro RCJ, Mackow ER, Baxter JD, West BL. Identification of a tumor necrosis factor-responsive element in the tumor necrosis factor α gene. J Biol Chem. 266:1991;9343-9346.
21. Rhoades KL, Cai S, Golub SH, Economou JS. Granulocyte-macrophage colony-stimulating factor and interleukin-4 differentially regulate the human tumor necrosis factor-α promoter region. Cell Immunol. 161:1995;125-131.
22. Olsson IL, Breitman TR. Induction of differentiation of the human histiocytic lymphoma cell line U937 by retinoic acid and cyclic 3′,5′-monophosphate-inducing agents. Cancer Res. 42:1982;3924.
23. Matikainen S, Hurme M. Comparison of retinoic acid and, phorbol myristate acetate as inducers of monocytic differentiation. Int J Cancer. 57:1994;98-103.
24. Caron E, Peyrard T, Kohler S, Cabane S, Liautard J-P, Dornand J. Live Brucella spp. fail to induce tumor necrosis factor alpha excretion upon infection of U937-derived phagocytes. Infect Immun. 62:1994;5267-5274.
25. Rhoades KL, Golub SH, Economou JS. The regulation of the human tumor necrosis factor α promoter region in macrophage, T cell, and B cell lines. J Biol Chem. 267:1992;22102-22107.
26. Jongeneel CV. Transcriptional regulation of the tumor necrosis factor α gene. Immunobiology. 193:1995;210-216.
27. Brinkman BMN, Zuijdgest D, Kaijzel EL, Breedveld FC, Verweij CL. Relevance of the tumor necrosis factor alpha (TNF-α) -308 promoter polymorphism in TNF-α gene regulation. J Inflamm. 46:1996;32-41.
28. Stuber F, Udalova IA, Book M, Drutskaya LN, Kuprash DV, Turetskaya RL, Schade FU, Nedospasov SA. -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J Inflamm. 46:1996;42-50.
29. Leitman DC, Ribeiro RJ, Mackow ER, Baxter JD, West BL. Identification of a tumor necrosis factor-responsive element in the tumor necrosis factor α gene. J Biol Chem. 266:1991;9343-9346.
30. Berendt AR, Simmons DL, Tansey J, Newbold CI, Marsh K. Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum. Nature. 341:1989;57-59.
31. Kwiatkowski D, Hill AVS, Sambou I, Twumasi P, Castracane J, Manogue KR, Cerami A, Brewster DR, Greenwood BM. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet. 336:1990;1202-1204.
32. Hussain MJ, Peakman M, Gallati H, Lo SSS, Hawa M, Viberti GC, Watkins PJ, Leslie RDG, Vergani D. Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia. 39:1996;60-69.
33. Dahlen E, Dawe K, Ohlsson L, Hedlund G. Dendritic cells and macrophages are the first and major producers of TNF-α in pancreatic islets in the nonobese diabetic mouse. J Immunol. 160:1998;3585-3593.